United States

Sumitomo Dainippon Pharma Co Ltd (4506.T)

4506.T on Tokyo Stock Exchange

2:00am EDT
Change (% chg)

¥36 (+1.65%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Sumitomo Dainippon Pharma Co., Ltd., is a pharmaceutical company. The Japan segment manufactures and sells ethical and general use drugs. The North America segment manufactures, develops, purchases and sells ethical drugs. The China segment manufactures and sells ethical drugs through its consolidated subsidiary. The Other... (more)


Beta: 0.43
Market Cap(Mil.): ¥865,830.81
Shares Outstanding(Mil.): 397.90
Dividend: 9.00
Yield (%): 0.83


  4506.T Industry Sector
P/E (TTM): 19.62 28.29 30.45
EPS (TTM): 110.93 -- --
ROI: 7.36 12.92 12.63
ROE: 9.38 14.94 14.82

BRIEF-Sumitomo Dainippon Pharma and JCR Pharmaceuticals sign license agreement

* Says it and JCR Pharmaceuticals Co Ltd signed a license agreement on Blood-Brain Barrier Penetration Technology for creation of a therapeutic agent for Central Nervous System Diseases

Feb 26 2018

BRIEF-Sumitomo Dainippon Pharma says change of president

* Says it appoints Masayo Tada as chairman of the board, and Hiroshi Nomura as president, effective April 1

Feb 23 2018

Earnings vs. Estimates